Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1651625/000095010320006219/dp124295_20f.htm
June 2022
June 2022
May 2022
April 2022
April 2022
March 2022
March 2022
November 2021
November 2021
October 2021
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1651625/000095010320006219/dp124295_20f.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Ac Immune Sa.
Ac Immune Sa's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 20-F Annual Report
Material Contracts, Statements, Certifications & more
Ac Immune Sa provided additional information to their SEC Filing as exhibits
Ticker: ACIU
CIK: 1651625
Form Type: 20-F Annual Report
Accession Number: 0000950103-20-006219
Submitted to the SEC: Mon Mar 30 2020 9:04:58 AM EST
Accepted by the SEC: Mon Mar 30 2020
Period: Tuesday, December 31, 2019
Industry: Pharmaceutical Preparations